September 15, 2025 Sharad Vadehra and Reena MP Singh Synergy, Obviousness, and Enablement: Key Takeaways from the Madras HC’s Amgen Decision View more September 12, 2025 Sharad Vadehra, Rachana Bishnoi, Daksh Oberoi Trademark Dispute Over “Pride”: Pernod Ricard India v. Karanveer Singh Chhabra View more September 8, 2025 Sharad Vadehra, Kanu Priya, Poonam Verma Implication of Revised CRI Guidelines for Emerging Technologies View more September 5, 2025 Sharad Vadehra, Kshitij Saxena, Saransh Vijaywargiya Draft Patents (Amendment) Rules, 2025: Digital Adjudication, Timelines, and Procedural Reforms View more August 18, 2025 Sharad Vadehra, Arathy P.B., Vibhanshu Singh Grace Period in Indian Patent Law View more August 6, 2025 Sharad Vadehra and Arpita Arora. Can a Biosimilar Reference Product Trigger Infringement? View more August 1, 2025 Sharad Vadehra, Shikha Baiswar, Reena MP Singh. Celator’s Patent Upheld against Post-Grant Oppositions filed by Cipla and Mylan View more July 25, 2025 Sharad Vadehra and Reena MP Singh Understanding the Difference between Section 3(d) and 3(e) through Oramed View more 1 2 … 22
